Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer

Journal of Medical Virology

Volumn 74, Issue 1, 2004, Pages 117-126

  Tornesello, Maria Lina ^a   Duraturo, Maria Luisa ^a   Salatiello, Immacolata ^a   Buonaguro, Luigi ^a   Losito, Simona ^a   Botti, Gerardo ^a   Stellato, Giovanni ^a   Greggi, Stefano ^a   Piccoli, Roberto ^b   Pilotti, Silvana ^b   Stefanon, Bernardina ^c   De Palo, Giuseppe ^c   Franceschi, Silvia ^d   Buonaguro, Franco M ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical intraepithelial neoplasia (CIN); HPV 16 E6 and E7; HPV 16 L1; HPV 16 long control region (LCR); HPV 16 variability; Italy

Indexed keywords

PROTEIN E6; PROTEIN E7;

ADULT; ARTICLE; CANCER GROWTH; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM; VIRUS ONCOGENE; VIRUS TYPING; WART VIRUS;

ADULT; AGED; CAPSID PROTEINS; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENES, VIRAL; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 3342998458     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20154     Document Type: Article

References (54)

1. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: A case-control study. J Natl Cancer Inst 93:1325-1330.
2. Bible JM, Mant C, Best JM, Kell B, Starkey WG, Shanti Raju K, Seed P, Biswas C, Muir P, Banatvala JE, Cason J. 2000. Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol 81:1517-1527.
3. Buonaguro FM, the Italian HPV Working Group. 2004. Human papillomaviruses and cervical lesions in the Italian population. Women Oncol Rev (in press).
4. Buonaguro FM, Tornesello ML, Beth-Giraldo E, Hatzakis A, Mueller N, Downing R, Biryamwaho B, Sempala SD, Giraldo G. 1996. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65:25-28.
5. Buonaguro FM, Tornesello ML, Salatiello I, Okong P, Buonaguro L, Beth-Giraldo E, Biryahwaho B, Sempala SD, Giraldo G. 2000. The uganda study on HPV variants and genital cancers. J Clin Virol 19:31-41.
6. Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, Wipf GC, Porter P, Daling JR, McDougall JK, Galloway DA. 2001. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61:1934-1940.
7. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003a. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105.
8. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003b. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73.
9. Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C. 2003. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 106:396-403.
10. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Young LS. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1:464-470.
11. Felsestein J. 1993. PHYLIP: Phylogeny inference package (version 3.5c). Department of Genetics, University of Washington, Seattle.
12. Ferenczy A, Franco E. 2003. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 3:11-16.
13. Franco EL, Villa LL, Rahal P, Ruiz A. 1994. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst 86:1558-1559.
14. Fredricks DN, Relman DA. 1999. Paraffin removal from tissue sections for digestion and PCR analysis. Biotechniques 26:198-200.
15. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
16. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423.
17. Human Papillomaviruses. 1997. Los Alamos National Laboratory, Los Alamos, New Mexico.
18. IARC monographs on the evaluation of carcinogenic risks to humans. 1995. Human Papillomaviruses.
19. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H. 2000. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81:1975-1981.
20. Kimura M. 1980. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120.
21. Kurvinen K, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S. 2000. Variants of the long control region of human papillomavirus type 16. Eur J Cancer 36:1402-1410.
22. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69:364-368.
23. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. 1992. Human papillomavirus infection of the cervix: Relative risk association of 15 common anogenital types. Obstet Gynecol 79:328-337.
24. Maciag PC, Schlecht NF, Souza PS, Rohan TE, Franco EL, Villa LL. 2002. Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. J Infect Dis 186:164-172.
25. Matsumoto K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, Kawana K, Sekiya S, Hirai Y, Kukimoto I, Kanda T, Taketani Y. 2000. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156:159-165.
26. McCance DJ, Kalache A, Ashdown KX, Andrade L, Menzes F, Smith P, Doll R. 1986. Human papillomavirus type 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer 37:55-59.
27. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. 1999. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplasia and cervical cancer. Int J Cancer 82:203-207.
28. Picconi MA, Alonio LV, Sichero L, Mbayed V, Villa LL, Gronda J, Campos R, Teyssie A. 2003. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J Med Virol 69:546-552.
29. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, Manos MM. 1990. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 82:1477-1484.
30. Riou G, Favre M, Jeannel D, Bourthis J, Le Doussal V, Orth G. 1990. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335:1171-1174.
31. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
32. Seedorf K, Krämmer G, Dürst M, Suhai S, Röwekamp WG. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
33. Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH, Lee HP. 1997. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 66:275-281.
34. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. 1996. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70:6987-6993.
35. Tornesello ML, Buonaguro FM, Beth-Giraldo E, Kyalwazi SK, Giraldo G. 1992. Human papillomavirus (HPV) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa. Int J Cancer 51:587-592.
36. Tornesello ML, Buonaguro FM, Meglio A, Buonaguro L, Beth-Giraldo E, Giraldo G. 1997. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol 78:2199-2208.
37. Tornesello ML, Buonaguro FM, Buonaguro L, Salatiello I, Beth-Giraldo E, Giraldo G. 2000. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol 81:2969-2982.
38. van de Peer Y, De Wachter R. 1993. TREECON: A software package for the construction and drawing of evolutionary trees. Comp Appl Biosci 9:177-182.
39. van den Brule AJ, Walboomers JMM, du Maine M, Kenemans P, Meijer CJLM. 1991, Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 48:404-408.
40. van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM. 2000. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81:317-325.
41. Veress G, Szarka K, Dong XP, Gergely L, Pfister H. 1999. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80:1035-1043.
42. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968.
43. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
44. Winship PR. 1989. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic acids Res 17:1266-1266.
45. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA. 1995. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172:747-755.
46. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
47. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Hawes SE, Surawicz C, Goldbaum G, Holmes KK, Kiviat NB. 1998. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 58:3839-3844.
48. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69:7743-7753.
49. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 71:2463-2472.
50. Zehbe I, Tommasino M. 1999. The biological significance of human papillomavirus type 16 variants for the development of cervical neoplasia. Papillomavirus Report 10:105-116.
51. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. 1998. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.
52. Zehbe I, Mytilineos J, Wikstrom I, Henriksen R, Edler L, Tommasino M. 2003. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol 64:538-542.
53. zur Hausen H. 1989. Papillomavirus in anogenital cancer: The dilemma of epidemiologic approaches. J Natl Cancer Inst 81: 1680-1682.
54. zur Hausen H. 1991. Viruses in human cancers. Science 254:1167-1173.